Partial Onset Seizures

Partial-Onset Seizure Treatment Discontinued

Partial-Onset Seizure Treatment Discontinued

By

Potiga tablets have been discontinued due to the limited use of the medicine.

Aptiom Aims for Pediatric Indication for Partial Onset Seizures

Aptiom Aims for Pediatric Indication for Partial Onset Seizures

By

Sunovion has filed a supplemental NDA with the FDA to expand the indication for Aptiom to pediatric patients with partial onset seizures.

FDA Approves IV Formulation of Carbamazepine for Seizures

FDA Approves IV Formulation of Carbamazepine for Seizures

By

The drug is the first and only IV formulation of the antiepileptic carbamazepine.

Lacosamide Monotherapy Safe, Effective for Long-Term Tx of Partial-Onset Seizures

Lacosamide Monotherapy Safe, Effective for Long-Term Tx of Partial-Onset Seizures

By

Results from a 2-year extension study confirm the safety and efficacy of lacosamid monotherapy.

IV Brivaracetam Safe, Effective Option for Epilepsy Patients

IV Brivaracetam Safe, Effective Option for Epilepsy Patients

By

Similar plasma concentration, adverse events observed compared to oral administration.

Epilepsy Surgery Reduces Mortality Rate

Epilepsy Surgery Reduces Mortality Rate

By

Surgery had a significant impact on mortality even if seizures were not completely eliminated.

Briviact Approved as Add-On Treatment for Partial-Onset Seizures

Briviact Approved as Add-On Treatment for Partial-Onset Seizures

By

The drug targets the synaptic vesicle protein 2A, which may contribute to the anticonvulsive effect.

Case Study: Surgical Tx of Refractory Seizures in a Child with Hx of AVM, ICH

Case Study: Surgical Tx of Refractory Seizures in a Child with Hx of AVM, ICH

By

Dr Mary Zupanc of CHOC Children's recounts a challenging case of refractory seizures in a child with a history of arteriovenous malformation and intracranial hemorrhage.

Brivaracetam Safe, Effective as Adjunct Therapy for Partial-Onset Seizures

Brivaracetam Safe, Effective as Adjunct Therapy for Partial-Onset Seizures

By

Both the 100 and 200 mg/d dose were found to be safe and effective in POS patients 16 years and older.

Sign Up for Free e-newsletters



CME Focus